Target intelligence / Profile preview

Neurobeachin pseudogene 2 (NBEAP2)

Target: NBEAP2
Molecular classification: Other (Pseudogene)

Overview

Neurobeachin pseudogene 2 (NBEAP2), also known as BCL8D, represents a predicted non-protein-coding pseudogene with sequence similarity to the neuronal protein-coding gene Neurobeachin (NBEA). The canonical Neurobeachin protein is involved in trafficking of synaptic membrane proteins, neuron development, synaptic transmission, and is implicated in autism and neurodevelopmental disorders[1][3][4]. However, there is no evidence that NBEAP2 is expressed as a protein, participates in molecular signaling, or serves as a receptor, enzyme, transporter, or transcription factor. There is currently no information supporting any role for NBEAP2 in disease, pharmacology, or physiology. Consequently, NBEAP2 is not regarded as a drug target, receptor, or biomarker.

Other names: BCL8DNBEAP2

Beyond the preview

Go deeper on Neurobeachin pseudogene 2 (NBEAP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurobeachin pseudogene 2 (NBEAP2).

Explore the full profile